BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9020946)

  • 1. [Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
    Asano M; Mori T; Takahashi K; Yasuno M
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):55-60. PubMed ID: 9020946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of continuous infusion of 5-fluorouracil and daily low-dose cisplatin for inoperable recurrent cancer of the stomach and colon].
    Satoh Y; Une Y; Fujisawa J; Sawaguchi Y; Muranaga S; Obara M; Uchino J
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):87-92. PubMed ID: 7826083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
    Ogura T; Hiramatsu Y; Araki H; Kojima Y; Nakagawa A; Nakagawa M; Kamiyama Y; Shirasaka T
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():433-8. PubMed ID: 8849289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].
    Shirasaka T; Yamamitsu S; Tsuji A; Terashima M; Hirata K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):832-45. PubMed ID: 10897209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
    Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma].
    Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
    González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
    Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of adjuvant chemotherapy using 5-fluorouracil, leucovorin and cis-diamminedichloroplatinum for patients with advanced and recurrent gastric cancer].
    Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S; Moriwaki R; Kohno M; Tadatomo H; Koyanagi Y
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):309-14. PubMed ID: 9051133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three successful case reports of advanced gastric cancer with chemotherapy].
    Yamamoto M; Niinobu T; Taniguchi H; Kotobuki T; Fukunaga K; Kawai M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1689-92. PubMed ID: 15553684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy of continuous infusion 5-fluorouracil and daily low-dose cisplatin in advanced gastrointestinal and lung adenocarcinoma].
    Sasaki K; Hirata K; Denno R; Oikawa I; Mukaiya M; Hiraike N; Yagihashi A; Takasaka H; Katsuramaki T; Yamashiro K; Yamamitsu S; Shirasaka T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):959-64. PubMed ID: 9212804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [UFT/CDDP treatment in advanced gastric cancer--case report].
    Suga S; Nagai H; Horiuchi Y; Ohkita T; Ibayashi J; Koyama Y
    Gan No Rinsho; 1989 Jan; 35(1):87-92. PubMed ID: 2493527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.